{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "The pharmaceutical industry's version of a campaign bus, the ''Help Is Here Express,'' has toured 25 states this year to spread the word about charity prescription programs sponsored by drug companies. But even as the bright orange bus travels from state to state enrolling patients in the programs, the assistance may be coming to a halt for thousands of elderly people.", "headline": {"main": "Another Choice for Elderly: Charity or Medicare?"}, "abstract": "New Medicare presription drug plan is causing some pharmaceutical companies to curtail or eliminate their charity programs for older people; some drug companies, which distributed free drugs with retail value of $4.1 billion last year to about three million to four million Americans, say patients cannot get drug subsidies from them and also participate in new Medicare prescription program; Dr Mark McClellan administrator of federal Centers for Medicare and Medicaid Services, says nothing prevents industry from continuing subsidies, as long as free or subsidized drugs are not counted toward Medicare co-payments or deductibles; Medicare Rights Center is monitoring changes in charity programs, which are aimed at people near poverty level, but who make too much to qualify for Medicaid; Eli Lilly is canceling its charity program altogether, while Bristol-Myers Squibb will notify patients that they can continue with charity program or sign up for Medicare plan; suggestions to retain charity programs, albeit in different format, discussed; photo (M)", "print_page": "1", "word_count": 1361, "_id": "4fd24e208eb7c8105d7ef499", "snippet": "Drug companies say people who choose a new Medicare prescription program may lose free medications they are getting now.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/11/07/business/07drug.html", "multimedia": [{"url": "images/2005/11/07/business/07drug.751.jpg", "subtype": "thumbnail", "legacy": {"hasthumbnail": "Y", "thumbnailheight": 75, "thumbnail": "images/2005/11/07/business/07drug.751.jpg"}, "type": "image", "height": 75}], "subsection_name": null, "keywords": [{"name": "persons", "value": "MCCLELLAN, MARK"}, {"name": "organizations", "value": "MEDICARE RIGHTS CENTER"}, {"name": "organizations", "value": "CENTERS FOR MEDICARE AND MEDICAID SERVICES"}, {"name": "organizations", "value": "LILLY, ELI, & CO"}, {"name": "organizations", "value": "BRISTOL-MYERS SQUIBB CO"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MEDICAID"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Stephanie", "rank": 1, "lastname": "SAUL"}], "original": "By STEPHANIE SAUL"}, "document_type": "article", "pub_date": "2005-11-07T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "Op-Ed", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "LAST week, President Bush released plans to prepare the nation for the possibility of an outbreak of deadly influenza, calling for Congress to appropriate $7.1 billion for research and the stockpiling of vaccines and antiviral drugs. As a summary of goals and strategies, the president's plans are commendable. But drafting them was the easy part. Putting them into effect will be the challenge. The problem with President Bush's plans is that they can't succeed in the current bureaucratic structure. Were the federal government ever entitled to the benefit of the doubt, it forfeited that presumption in the aftermath of Hurricane Katrina. Unless these shortcomings are fixed, we have no grounds to presume the administration's laudable avian flu strategies will be translated into action.", "headline": {"main": "To Fight the Flu, Change How Government Works", "kicker": "Op-Ed Contributors"}, "abstract": null, "print_page": "13", "word_count": 763, "_id": "4fd2a9fc8eb7c8105d895550", "snippet": "The problem with President Bush's plans to combat an outbreak of deadly influenza is that they can't succeed in the government's current bureaucratic structure.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/11/06/opinion/06gingrich.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "AVIAN INFLUENZA"}, {"name": "subject", "value": "EPIDEMICS"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Newt", "rank": 1, "lastname": "Gingrich"}, {"organization": "", "role": "reported", "firstname": "Robert", "rank": 2, "lastname": "Egge"}], "original": "By Newt Gingrich and Robert Egge"}, "document_type": "article", "pub_date": "2005-11-06T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "AT the turn of the last century, a new phenomenon arose in America: the chain store. The most dominant chain was the Great Atlantic and Pacific Tea Company -- A.& P. -- which by 1930 had become the country's fifth-largest corporation, with $1 billion in sales, and was ''opening stores at a rate unprecedented in the history of American retailing,'' according to Richard S. Tedlow, the author of ''New and Improved: The Story of Mass Marketing in America.'' The New York Times described A.& P. that year as ''the world's greatest retailing machine.'' Its president, John A. Hartford, attributed the company's success to its policy ''of immediately passing on reductions in wholesale commodity prices to the consumer,'' as The Times put it. Under Hartford, writes Mr. Tedlow, ''A.& P. had one dominant mission: to sell quality food at low prices.''", "headline": {"main": "Our Love-Hate Relationship With Wal-Mart"}, "abstract": null, "print_page": "1", "word_count": 1494, "_id": "4fd2a9fc8eb7c8105d895523", "snippet": "For most of its existence, Wal-Mart was lauded. But now that it vies with Exxon Mobil as the largest company in the country, the worm has turned.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/11/05/business/05nocera.html", "multimedia": [{"width": 610, "url": "http://select.nytimes.com/packages/khtml/2005/10/14/business/20051015_NOCERA_AUDIOSS.html", "pay": "y", "rank": "1", "height": 625, "caption": "Getting Companies to Change Their Ways", "legacy": {"MultimediaPopupHeight1": "625", "MultimediaType1": "Other", "MultimediaPopupWidth1": "610", "MultimediaUrl1": "http://select.nytimes.com/packages/khtml/2005/10/14/business/20051015_NOCERA_AUDIOSS.html", "MultimediaPay1": "y", "MultimediaHeadline1": "Getting Companies to Change Their Ways", "MultimediaCol1": "Audio"}, "type": "Other", "col": "Audio"}, {"subtype": "thumbnail", "legacy": {"hasthumbnail": "Y", "thumbnailheight": 75}, "type": "image", "height": 75}, {"subtype": "tiny_thumb", "legacy": {"tinythumbwidth": 55, "tinythumbheight": 55, "hastinythumb": "Y"}, "type": "image", "width": 55, "height": 55}], "subsection_name": null, "keywords": [{"name": "organizations", "value": "WAL-MART STORES INCORPORATED"}, {"name": "subject", "value": "LABOR"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Joseph", "rank": 1, "lastname": "NOCERA"}], "original": "By JOSEPH NOCERA"}, "document_type": "article", "pub_date": "2005-11-05T00:00:00Z", "section_name": "Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "To understand what drives him to run for governor of New Jersey, Douglas R. Forrester says you can look to Moonlight Graham, a right fielder for the 1905 New York Giants. To understand how he might govern if elected on Tuesday, his friends say you can find clues in a former president, Jimmy Carter.", "headline": {"main": "THE RACE FOR TRENTON: The Republican; Forrester Makes A Dogged Ascent Despite Setbacks"}, "abstract": "Article in series The Race for Trenton examines life and career of Douglas R Forrester, Republican candidate for governor of New Jersey; he grew up in lower-middle-class family and went on to study at Harvard and then Princeton; co-founded pharmaceutical company, with work style that friends describe as that of micromanager; has already mapped out his first 100 days in office; says he will do 'direct, hands-on budget work' on state's $28 billion budget; considers himself moderate Republican in tradition of his former boss Thomas H Kean, who served two terms in 1980's; his personal wealth, estimated at $50 million, is less than that of his opponent Sen Jon Corzine; photos (L)", "print_page": "1", "word_count": 2528, "_id": "4fd264538eb7c8105d8177e5", "snippet": "To understand what drives him to run for governor of New Jersey, the candidate says look to a right fielder for the 1905 New York Giants.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/11/03/nyregion/metrocampaigns/03forrester.html", "multimedia": [{"url": "images/2005/11/03/nyregion/03forrester75.jpg", "subtype": "thumbnail", "legacy": {"hasthumbnail": "Y", "thumbnailheight": 75, "thumbnail": "images/2005/11/03/nyregion/03forrester75.jpg"}, "type": "image", "height": 75}], "subsection_name": null, "keywords": [{"name": "persons", "value": "CORZINE, JON S."}, {"name": "persons", "value": "KEAN, THOMAS H"}, {"name": "persons", "value": "FORRESTER, DOUGLAS R"}, {"name": "persons", "value": "CORZINE, JON S"}, {"name": "glocations", "value": "NEW JERSEY"}, {"name": "subject", "value": "SURVEYS AND SERIES"}, {"name": "subject", "value": "FINANCES"}, {"name": "subject", "value": "ELECTION ISSUES"}, {"name": "subject", "value": "BIOGRAPHICAL INFORMATION"}, {"name": "subject", "value": "GOVERNORS (US)"}, {"name": "subject", "value": "BUDGETS AND BUDGETING"}, {"name": "subject", "value": "ELECTIONS"}], "byline": {"person": [{"firstname": "David", "middlename": "W.", "lastname": "CHEN", "rank": 1, "role": "reported", "organization": ""}], "original": "By DAVID W. CHEN"}, "document_type": "article", "pub_date": "2005-11-03T00:00:00Z", "section_name": "Front Page; New York and Region"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "The Bush administration's long-awaited plan to deal with the threat of pandemic flu received a mixed reception on Capitol Hill Wednesday, as senators chided top health officials as taking too long and questioned their spending priorities. Senator Arlen Specter, Republican of Pennsylvania, asked Health and Human Services Secretary Michael O. Leavitt why the plan had taken years to complete. Top government health officials started drafting the plan in 1991.", "headline": {"main": "Administration's Flu Plan Gets Mixed Reception in Congress"}, "abstract": null, "print_page": "20", "word_count": 841, "_id": "4fd264538eb7c8105d8177d7", "snippet": "The Bush administration's long-awaited plan to deal with the threat of pandemic flu received a mixed reception on Capitol Hill Wednesday, as senators chided top health officials as taking too long and questioned their spending priorities.     Senator...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9D0DE3D8163EF930A35752C1A9639C8B63", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Gardiner", "rank": 1, "lastname": "HARRIS"}], "original": "By GARDINER HARRIS"}, "document_type": "article", "pub_date": "2005-11-03T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Health&Fitness", "lead_paragraph": "Ginseng, long recommended as a treatment for colds by proponents of herbal medicine, has gained some support in a controlled scientific experiment. Canadian researchers tested North American ginseng extract against a placebo and found that it had a small but significant effect in reducing the number and intensity of colds. The study, published in the Oct. 25 issue of The Canadian Journal of Medicine, tested 323 subjects. Volunteers were randomly assigned either to a group that took 200-milligram tablets of a commercial product with a known quantity of North American ginseng extract or to a group that took identical tablets of rice powder. An independent company randomly assigned the subjects, and neither the researchers nor the volunteers knew which pills were given to which participants.", "headline": {"main": "Ginseng May Reduce Number and Severity of Colds"}, "abstract": null, "print_page": "10", "word_count": 619, "_id": "4fd2510b8eb7c8105d7f5056", "snippet": "A controlled scientific experiment found that ginseng had a small but significant effect in reducing the number and intensity of colds.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/11/01/health/01gins.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "COLDS"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Nicholas", "rank": 1, "lastname": "BAKALAR"}], "original": "By NICHOLAS BAKALAR"}, "document_type": "article", "pub_date": "2005-11-01T00:00:00Z", "section_name": "Health"}, {"type_of_material": "Series", "blog": [], "news_desk": "Health&Fitness", "lead_paragraph": "Bernyce Edwards's daughter was 42 in 1997 when she died of breast cancer. It was just 69 days from diagnosis to death. And through her shock and grief, Ms. Edwards had a terrible worry: what if she got breast cancer, too? ''That's my biggest fear,'' she said.", "headline": {"main": "But Will It Stop Cancer?", "kicker": "Preventing Cancer"}, "abstract": null, "print_page": "1", "word_count": 2645, "_id": "4fd262f88eb7c8105d814c4b", "snippet": "Researchers disagree about whether exercise can prevent the disease, but see some promising evidence for breast and colon cancer.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/11/01/science/01canc.html", "multimedia": [{"url": "images/2005/11/01/science/01canc.75.jpg", "subtype": "thumbnail", "legacy": {"hasthumbnail": "Y", "thumbnailheight": 75, "thumbnail": "images/2005/11/01/science/01canc.75.jpg"}, "type": "image", "height": 75}], "subsection_name": null, "keywords": [{"name": "subject", "value": "EXERCISE"}, {"name": "subject", "value": "CANCER"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Gina", "rank": 1, "lastname": "KOLATA"}], "original": "By GINA KOLATA"}, "document_type": "article", "pub_date": "2005-11-01T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Health&Fitness", "lead_paragraph": "You don't have to look far -- at the hands (and feet) of women in all walks of life, at the displays in every pharmacy, at the nail salons that have proliferated around the country -- to realize that nails are in. There are more than 50,000 nail salons in the United States, and women (with the help of some men) spend more than $6 billion a year on nail care and cosmetics, from base coats and polish to wraps, silks, acrylics and tips.", "headline": {"main": "Sometimes, Your Nails Can Bite You Back", "kicker": "PERSONAL HEALTH"}, "abstract": null, "print_page": "8", "word_count": 1173, "_id": "4fd2692f8eb7c8105d81f6a6", "snippet": "Taking care of your nails is important, as the recent cosmetic rage may have untoward consequences.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/11/01/health/01brody.html", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [{"firstname": "Jane", "middlename": "E.", "lastname": "Brody", "rank": 1, "role": "reported", "organization": ""}], "original": "By Jane E. Brody"}, "document_type": "article", "pub_date": "2005-11-01T00:00:00Z", "section_name": "Health"}], "meta": {"hits": 8, "offset": 0, "time": 35}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}